Sign In
Last checked at 
21 May 2025 15:00
SMITH & NEPHEW PLC
21 May 2025
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020
On 20 May 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.
All figures in these columns are stated to 6 decimal places where applicable.
i. VESTING OF PERFORMANCE SHARE PLAN AWARDS MADE UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020
The awards were granted under the Global Share Plan 2020 and vested on 20 May 2025 at 59.35% of target. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards as detailed in the table below. The number of Shares acquired includes the dividend equivalent Shares which the participant received on the vested Shares. The table below sets out the number of shares under award which vested. The remaining shares under award have lapsed.
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Vesting on 20 May 2025 of Performance Share Plan awards granted under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability |
Date of Transaction | 2025 - 05 - 20 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) |
Status | Price (£) | Volume | Aggregated information |
Deepak Nath (Chief Executive Officer) | PDMR | 10.875359 | 83,938 (of which 34,477 were sold and 49,461 were retained) | N/A Single Transaction |
ii. VESTING OF CONDITIONAL AWARDS MADE UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020
The awards were granted under the Global Share Plan 2020 and vested on 20 May 2025. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards as detailed in the table below.
The following relates to individuals included in the below notification:
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Vesting on 20 May 2025 of Conditional Share awards granted under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability |
Date of Transaction | 2025 - 05 - 20 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) |
Status | Price (£) | Volume | Aggregated information |
Craig Gaffin (President, Global Orthopaedics) | PDMR | 10.875359
| 1,551 (of which 379 were sold and 1,172 were retained) | N/A Single Transaction |
Elga Lohler (Chief HR Officer) | PDMR | 10.875359 | 20,174 (of which 8,026 were sold and 12,148 were retained) | N/A Single Transaction |
Vasant Padmanabhan (President Research & Development and ENT) | PDMR | 10.875359 | 19,626 (of which 8,708 were sold and 10,918 were retained) | N/A Single Transaction |
Rohit Kashyap (President, Advanced Wound Management and Global Commercial Operations) | PDMR | 10.875359 | 11,949 (of which 2,920 were sold and 9,029 retained) | N/A Single Transaction |
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
Follow the stocks
